Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole
NCT00942773 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2010-03-04
Summary
The purpose of this study is to:
* Evaluate the influence of CYP2C19 genotype on PK profiles of voriconazole.
Conditions
- Healthy
Interventions
- DRUG
-
Voriconazole
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
NCT04743544 ·Status: UNKNOWN
-
Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism
NCT00175994 ·Status: COMPLETED
-
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
NCT01148160 ·Status: TERMINATED
-
A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen
NCT03760276 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults
NCT00855101 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
NCT02631954 ·Status: COMPLETED ·Phase: PHASE1
-
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
NCT02100761 ·Status: UNKNOWN
-
Pharmacokinetics of Two Different Formulation of Voriconazole
NCT02912156 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)
NCT01657201 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
NCT01416025 ·Status: COMPLETED ·Phase: PHASE4
-
MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT02227797 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
NCT00647907 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacologic Optimization of Voriconazole
NCT00893555 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
NCT00174473 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Voriconazole to Treat Fungal Infections
NCT00001940 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
NCT00288197 ·Status: COMPLETED ·Phase: PHASE4
-
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
NCT03731169 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients
NCT03067350 ·Status: COMPLETED
-
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
NCT00740389 ·Status: COMPLETED ·Phase: PHASE1
-
Voriconazole Blood Levels and Toxicity
NCT00359541 ·Status: COMPLETED
-
Evaluate Bioequivalence of Voriconazole(200mg/Vial) .
NCT04552353 ·Status: COMPLETED ·Phase: PHASE4
-
Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
NCT00745992 ·Status: COMPLETED
-
Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects
NCT04872231 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Inflammation on Voriconazole Concentration
NCT02074462 ·Status: COMPLETED
-
Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects
NCT05330000 ·Status: COMPLETED ·Phase: PHASE1